Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-016005
Filing Date
2025-04-28
Accepted
2025-04-28 16:01:46
Documents
24
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20042039x2_def14a.htm   iXBRL DEF 14A 1839980
6 GRAPHIC ny20042039x2_graph01.jpg GRAPHIC 145059
7 GRAPHIC ny20042039x2_pc01.jpg GRAPHIC 717243
8 GRAPHIC ny20042039x2_pc02.jpg GRAPHIC 683436
9 GRAPHIC ny20042039x2_piechart01.jpg GRAPHIC 102964
10 GRAPHIC ny20042039x2_pvp01.jpg GRAPHIC 177959
11 GRAPHIC ny20042039x2_pvp02.jpg GRAPHIC 144551
  Complete submission text file 0001140361-25-016005.txt   7897896

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA advm-20250617.xsd EX-101.SCH 3892
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE advm-20250617_def.xml EX-101.DEF 3024
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE advm-20250617_lab.xml EX-101.LAB 2971
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE advm-20250617_pre.xml EX-101.PRE 6376
27 EXTRACTED XBRL INSTANCE DOCUMENT ny20042039x2_def14a_htm.xml XML 211036
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 25880136
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)